نتایج جستجو برای: chronic obstructive pulmonary disease copd

تعداد نتایج: 1934966  

Journal: :International journal of developmental research 2023

Photobiomodulation is the use of visible and infrared light through emitting diodes - LED without thermal cytotoxic reactions.It was carried out a literature review with this studyto understand photobiomodulation applied to Chronic Obstructive Pulmonary Disease COPD.It survey in January 2023, SciELO, Lilacs, Pubmed, Medline Google Scholar databases. With descriptors “Low-level therapy” AND “Chr...

Journal: :The New England journal of medicine 2003
Earl P Steinberg

2681 prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003;348:2618-25. 12. Snow V, Lascher S, Mottur-Pilson C. The evidence base for management of acute exacerbations of COPD: clinical practice guideline. Chest 2001;119:1185-9. 13. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disea...

Journal: :The European respiratory journal. Supplement 2001
M G Cosio Piqueras M G Cosio

The pathological hallmarks of chronic obstructive pulmonary disease (COPD) are inflammation of the small airways (bronchiolitis) and destruction of lung parenchyma (emphysema). The functional consequence of these abnormalities is airflow limitation. Airway abnormalities and emphysema interact in a complex fashion in the development of airflow limitation in COPD. In an attempt to improve underst...

Objectives Chronic Obstructive Pulmonary Disease (COPD) is one of the most important progressive pulmonary disorders. Diaphragmatic dysfunction is an essential factor in the worsening and progression of symptoms in patients with COPD. Therefore, we investigated the effect of diaphragmatic respiratory training on some pulmonary indexes in these patients. Methods & Materials This quasi-experimen...

Journal: :Journal of Thoracic Disease 2023

Background: Lung volume reduction (LVR) and lung transplantation (LTx) have been used in different populations of chronic obstructive pulmonary disease (COPD) patients. To date, comparative study LVR LTx has not performed. We sought to address this gap by pooling the existing evidence literature.

Journal: :The European respiratory journal 2006
M I Restrepo E M Mortensen J A Pugh A Anzueto

Patients with chronic obstructive pulmonary disease (COPD) who develop community-acquired pneumonia (CAP) may experience worse clinical outcomes. However, COPD is not included as a distinct diagnosis in validated instruments that predict mortality in patients with CAP. The aim of the present study was to evaluate the impact of COPD as a comorbid condition on 30- and 90-day mortality in CAP pati...

Journal: :The European respiratory journal 2006
A Zandvoort Y M van der Geld M R Jonker J A Noordhoek J T W M Vos J Wesseling H F Kauffman W Timens D S Postma

Chronic obstructive pulmonary disease (COPD) is characterised by destruction of extracellular matrix (ECM) in parenchymal areas, whereas the bronchial walls can show fibrosis. In addition, an extensive inflammatory process is observed. CD8+ T-cells, located throughout the lung, and epithelial cells in centrally located airways, produce cytokines involved in the inflammatory process. These cytok...

Journal: :Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2007
Elena Doina Murărescu Elena Cristina Mitrofan Maria Sultana Mihailovici

Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to ...

Journal: :Medical research archives 2023

Chronic obstructive pulmonary disease (COPD) is chronic that affects mostly the lungs but there growing evidence it also a systemic condition associated with number of accompanying diseases known as comorbidities. inflammation and oxidative stress are highlight pathogenic processes interrelate COPD comorbidities additional specific risk factors mechanisms. Through complex interactions increases...

Journal: :The Journal of the Association of Physicians of India 2015
Ashok A Mahashur Jai B Mullerpattan

C pulmonary diseases, a s m a i n l y d e f i n e d b y asthma, bronchiectasis, chronic obstructive lung disease (COPD), interstitial lung disease, pulmonary hypertension etc., represent the third leading cause of death in United States and account for more than 143,382 deaths in 201148. The prevalence of chronic obstructive pulmonary disease (COPD) in India is estimated to be 31.4–57.1% over 6...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید